About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Announces Results of TPM Oxycodone Phase 2a Trial

January 29, 2016

Click here to read more

Post navigation

Phosphagenics Reports Positive Resuls for Weaner Pig Efficiency Trial

Phosphagenics Newsletter – February 2016

Related Posts

Receipt of R&D Tax Incentive

March 1, 2017

Phosphagenics Announces Transition of Chairman of Board

April 21, 2017

Appendix 3X Notices – Three New Directors

April 22, 2015

Recent Posts

Quarterly Activities Report and 4C – to 30 June 2022
July 29, 2022
MEDIA | Hand it to cannabis
May 5, 2022
Quarterly Activities Report and 4C to 31 March 2022
April 29, 2022

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.